25Jun
Blog: SEC Amendments to Financial Disclosure Requirements Provide a Welcome Reprieve for Carve-Out Transactions
As previously reported in this Cooley PubCo post, on May 21, the SEC adopted final amendments to the financial disclosure requirements for the acquisition and disposition of businesses. One change relating to the use of abbreviated financial statements stands out as a welcome reform for public or pre-public biopharma and life sciences companies....
By:
Cooley LLP
Related
The US Department of Homeland Security (DHS) announced that it will no longer allow New York residen...
Read More >
On September 14, 2020, Division One of the Washington Court of Appeals provided clarification in the...
Read More >
A new Chicago ordinance places complicated restrictions on how employers in 7 industries can schedul...
Read More >
On 4 February 2021 the Federal Trade Commission (FTC) announced that U.S. antitrust agencies will te...
Read More >
In its 2012 Hosanna-Tabor decision, the U.S. Supreme Court first recognized the existence of a “min...
Read More >
CHINESE OUTBOUND INVESTMENTS – THE SELLER’S PERSPECTIVE - 1. CHINESE REGULATION – 1.1 The Chi...
Read More >